Europe Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

List of Tables

The Europe poultry vaccines market was valued at US$ 321.82 million in 2023 and is expected to reach US$ 635.01 million by 2031; it is estimated to record a CAGR of 8.9% from 2023 to 2031.

Growing Poultry Industry Drives Europe Poultry Vaccines Market

According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world's largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. These countries include the US, Brazil, the European Union (EU), and Thailand, which are also major poultry exporters. According to the Council on Foreign Relations 2024 report, the US, Brazil, the European Union, and Thailand account for 71% of the world's poultry exports in 2021. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.

Europe Poultry Vaccines Market Overview

In Germany, poultry disease outbreaks are rising significantly. For instance, Germany experienced the largest HPAI outbreak on record between November 2020 and May 2021. The outbreak affected 245 poultry; captive bird farms; and over 1,000 wild birds. Additionally, vaccination against Newcastle Disease is a crucial control measure in countries such as Germany, where the virus is common in the free-ranging bird population. The German Standing Veterinary Committee on Immunization (StIKo Vet) recommends revaccinating chickens every six weeks with attenuated live vaccines via drinking water or spray, following the Summary of Product Characteristics (SPCs) of current vaccines. Furthermore, Eimeria vaccination is an important practice in laying hens, both caged and free-range birds, to prevent and manage the possibility of suffering an outbreak of coccidiosis produced by Eimeria spp. during the rearing of "male brother chicks" of the layer breeds and mixed genetics chicks. Therefore, all these factors are contributing to the growth of the poultry vaccines market in Germany.

Europe Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Europe Poultry Vaccines Market Segmentation

The Europe poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Europe poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Europe poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Europe poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Europe poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Europe poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Europe poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Europe poultry vaccines market is segmented into Germany, Spain, France, the UK, Italy, and the Rest of Europe. Germany dominated the Europe poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, BIOVAC, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Europe poultry vaccines market.

Product Code: BMIRE00025385

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

4. Europe Poultry Vaccines Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Poultry Diseases
- 4.1.2 Growing Poultry Industry
4.2 Market Restraints
- 4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
- 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
- 4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:

5. Europe Poultry Vaccines Market Analysis

5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Europe Poultry Vaccines Market Analysis - by Type

6.1 Overview
6.2 Broiler
- 6.2.1 Overview
- 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
- 6.3.1 Overview
- 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Poultry Vaccines Market Analysis - by Technology

7.1 Overview
7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
- 7.3.1 Overview
- 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
- 7.4.1 Overview
- 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Poultry Vaccines Market Analysis - by Dosage Form

8.1 Overview
8.2 Liquid Vaccines
- 8.2.1 Overview
- 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
- 8.3.1 Overview
- 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
- 8.4.1 Overview
- 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Poultry Vaccines Market Analysis - by Disease

9.1 Overview
9.2 Avian Influenza
- 9.2.1 Overview
- 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
- 9.3.1 Overview
- 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Marek's Disease
- 9.4.1 Overview
- 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
- 9.5.1 Overview
- 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
- 9.6.1 Overview
- 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
- 9.7.1 Overview
- 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
9.8 Others
- 9.8.1 Overview
- 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Poultry Vaccines Market Analysis - by Route of Administration

10.1 Overview
10.2 Drinking Water (D/W)
- 10.2.1 Overview
- 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
- 10.3.1 Overview
- 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
- 10.4.1 Overview
- 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Poultry Vaccines Market Analysis - by End User

11.1 Overview
11.2 Poultry Farms
- 11.2.1 Overview
- 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
- 11.3.1 Overview
- 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
- 11.4.1 Overview
- 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Poultry Vaccines Market - Country Analysis

12.1 Europe Market Overview
- 12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis - by Country
  - 12.1.1.1 Germany: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.1.1 Overview
    - 12.1.1.1.2 Germany: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.1.3 Germany: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.1.4 Germany: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.1.5 Germany: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.1.6 Germany: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.1.7 Germany: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.2 Spain: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.2.1 Overview
    - 12.1.1.2.2 Spain: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.2.3 Spain: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.2.4 Spain: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.2.5 Spain: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.2.6 Spain: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.2.7 Spain: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.3 France: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.3.1 Overview
    - 12.1.1.3.2 France: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.3.3 France: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.3.4 France: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.3.5 France: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.3.6 France: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.3.7 France: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.4 United Kingdom: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.4.1 Overview
    - 12.1.1.4.2 United Kingdom: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.4.3 United Kingdom: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.4.4 United Kingdom: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.4.5 United Kingdom: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.4.6 United Kingdom: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.4.7 United Kingdom: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.5 Italy: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.5.1 Overview
    - 12.1.1.5.2 Italy: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.5.3 Italy: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.5.4 Italy: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.5.5 Italy: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.5.6 Italy: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.5.7 Italy: Poultry Vaccines Market Breakdown by End User
  - 12.1.1.6 Rest of Europe: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.1.1.6.1 Overview
    - 12.1.1.6.2 Rest of Europe: Poultry Vaccines Market Breakdown by Type
    - 12.1.1.6.3 Rest of Europe: Poultry Vaccines Market Breakdown by Technology
    - 12.1.1.6.4 Rest of Europe: Poultry Vaccines Market Breakdown by Dosage Form
    - 12.1.1.6.5 Rest of Europe: Poultry Vaccines Market Breakdown by Disease
    - 12.1.1.6.6 Rest of Europe: Poultry Vaccines Market Breakdown by Route of Administration
    - 12.1.1.6.7 Rest of Europe: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
- 13.3.1 Overview
13.1 Inorganic Developments
- 13.1.1 Overview

14. Company Profiles

14.1 Boehringer Ingelheim International GmbH
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Zoetis Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Phibro Animal Health Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Elanco Animal Health Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck KGaA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Ceva
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Vaccinova AB
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms